Acknowledgment of Receipt received from all parties with respect to Order (Doc. No. 20). placed on file on 17-APR-2014

Order dated 17-APR-2014 rendered by The Honourable Mr. Justice Roy Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 15-APR-2014 Result: "THIS COURT ORDERS that 1. The REspondent Minister of Health is prohibited from issuing a Notice of Compliance (NOC) to the Respondent Cobalt Pharmaceuticals Company in respect of its 100 mg and 400 mg tablets containing imatinib mesylate as its active ingredient until the expiry of Canadian Patents 2,489,199 and 2,622,808 or such earlier date upon which the owner of the patents notifies the Minister of Health in writing of itsd consent to the making, constructing, using or selling of the drug in Canada by Cobalt Pharmaceuticals Company; 2. There shall be no Order of costs in respect of this proceeding." Filed on 17-APR-2014 entered in J. & O. Book, volume 1226 page(s) 410 - 411 Final Decision

Communication to the Court from the Registry dated 15-APR-2014 re: letter, consent and draft Order received April 15, 2014

Consent on behalf of all parties to the Order attached hereto for a prohibition Order filed on 15-APR-2014

Letter from Applicant dated 15-APR-2014 advising that the parties have agreed to a consent Order prohibiting the Minister from issuing regulatory approval to Cobalt until the expiry of Canadian Patents 2,483,199 and 2,622,808 and attaching a draft prohibition Order and fully executed consent. The Applicant advises that the hearing dates for this matter scheduled for September 22-24, 2014 are no longer required. received on 15-APR-2014

Confirmation of received via facsimile received from all parties with respect to Doc. #18 placed on file on 25-OCT-2013

Order (time and place) dated 25-OCT-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 22-SEP-2014 to begin at 09:30 duration: 3d language: E Filed on 25-OCT-2013 cc's sent to parties entered in J. & O. Book, volume 1208 page(s) 308 - 308 Transmittal letters placed on file

Communication to the Court from the Registry dated 22-OCT-2013 re: File sent to TrialJA to set down hearing date

Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. #16 upon Respondent/POatentee Novartis AG by personal service on 18-OCT-2013 confirming service Doc. #16 upon Respondent - Cobalt Pharmaceuticals Company by telecopier on 18-OCT-2013 confirming service Doc. #16 upon Respondent - Minister of Health by telecopier on 18-OCT-2013 filed on 18-OCT-2013

Requisition for hearing - Application from Applicant filed on 18-OCT-2013 Tariff Application or appeal - $50.00

Solicitor's certificate of service on behalf of NICHOLAS WONG, Solicitor for the Respondent, Cobalt Pharmaceuticals Co. confirming service of COBALT'S AFFIDAVIT upon Applicant by Courier on 17-OCT-2013 confirming service COBALT'S AFFIDAVIT upon Respondent/Patentee by Courier on 17-OCT-2013 confirming service COBALT'S AFFIDAVIT upon The Respondent, THe Minister of Health by by hand on 17-OCT-2013 filed on 18-OCT-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Order of the Court dated 13-SEP-2013 placed on file on 13-SEP-2013

Order dated 13-SEP-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 11-SEP-2013 Result: "1. Cobalt shall serve its affidavit evidence on invalidity and responding evidence on infringement by October 18, 2013. 2. A requisition for hearing shall be filed by October 18, 2013. 3. Novartis shall serve its responding affidavit evidence on invalidity by January 20, 2014. 4. A full motion record on any motion for reply shall be filed by February 3, 2014. Such motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 5. Cross-examinations shall be completed by April 1, 2014. 6. Novartis' application record shall be served and filed by May 31, 2014. 7. Cobalt's application record shall be served and filed by July 31, 2014." Filed on 13-SEP-2013 copies sent to parties entered in J. & O. Book, volume 1204 page(s) 458 - 459 Interlocutory Decision

Communication to the Court from the Registry dated 11-SEP-2013 re: letter dated 11-SEP-2013

Letter from Respondent Cobalt Pharmaceuticals Company dated 11-SEP-2013 on behalf of the corporate parties, proposing further revisions to the schedule in response to the Directions dated 30-AUG-2013 received on 11-SEP-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 30-AUG-2013 placed on file on 04-SEP-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-AUG-2013 directing that "Can the parties confirm to the Court that they have considered and are satisfied that the amendments sought will not necessitate amendments to the remaining parts of the schedule and more particularily, that they are satisfied that despite a shorter time frame, they will be able to conclude cross-examinations on affidavits by April 1, even if a motion for reply were to be heard and granted after February 3, 2014." placed on file on 03-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 28-AUG-2013 re: letter received from the Respondent, Cobalt, on 28-AUG-2013

Letter from Respondent dated 28-AUG-2013 requesting, on consent of the corporate parties, extensions to the timetable as set out in the Order of the Court dated February 7, 2013 and as amended by direction dated May 31, 2013. received on 28-AUG-2013

Acknowledgment of Receipt received from all parties with respect to Protective Order Doc. 13 placed on file on 15-JUL-2013

Protective Order dated 15-JUL-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 05-JUL-2013 Result: granted Filed on 15-JUL-2013 copies sent to parties entered in J. & O. Book, volume 1199 page(s) 315 - 323 Interlocutory Decision

Communication to the Court from the Registry dated 08-JUL-2013 re: draft Protective Order approved by all parties as to form received July 5, 2013

Letter from Applicant dated 05-JUL-2013 advising that the parties have agreed on the form of a Protective Order. A Draft Protective Order is attached. received on 05-JUL-2013

Solicitor's certificate of service on behalf of John Norman confirming service of the Factual and Infringement evidence upon Respondent/Patentee - Novartis AG by personal service on 28-JUN-2013 confirming service the Factual and Infringement evidence of the Applicant upon Respondents by courier on 28-JUN-2013 filed on 02-JUL-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-MAY-2013 directing that "The deadlines set out in paragraphs 3 and 4 of the Order of 7-FEB-2013 are extended by 30 days." placed on file on 31-MAY-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 31-MAY-2013 re: letters dated 29-MAY-2013 and 30-MAY-2013

Letter from Applicant dated 30-MAY-2013 further to their letter dated 29-MAY-2013, advising that the parties have now agreed to a 30 day extension of time (until 30-JUN-2013) for the Applicant to serve its evidence. received on 30-MAY-2013

****** CANCELLED ****** Communication to the Court from the Registry dated 30-MAY-2013 re: letter dated 29-MAY-2013

Letter from Applicant dated 29-MAY-2013 "Pursuant to the 7-FEB-2013 Order of Madam Prothonotary Tabib, the Applicant's factual evidence on invalidity and its infringement evidence in the within proceeding is to be served by 31-MAY-2013. Recent circumstances have arisen, including detailed negotiations between the parties, such that the Applicant wishes for the deadline for the service of its factual evidence on invalidity and its infringement evidence to be extended by a period of two weeks to the date of 14-JUN-2013 to continue negotiations. Counsel for the Applicant and the Respondent Cobalt are available on Friday May 31st to discuss this proposed scheduling change." received on 29-MAY-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 11 placed on file on 07-FEB-2013

Order dated 07-FEB-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 25-JAN-2013 Result: granted 1. Cobalt shall provide its productions from its ANDS (Cobalt imatinib formulation and properties) by 11-FEB-2013. 2. Novartis shall serve and file a full Motion Record on any Motion pursuant to section 6(7), by 25-FEB-2013. The record is to be accompanied by a letter setting out a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 3. Novartis shall serve its affidavit evidence on infringement and factual evidence on invalidity by 31-MAY-2013. 4. Cobalt shall serve and file a full Motion Record on any Motion pursuant to section 6(5) by 14-JUN-2013. The record is to be accompanied by a letter as per paragraph 2. 5. Cobalt shall serve its affidavit evidence on invalidity and responding evidence on infringement by 30-AUG-2013. 6. A Requisition for Hearing shall be filed by 30-AUG-2013. 7. Novartis shall serve its responding affidavit evidence on invalidity by 29-NOV-2013. 8. A full Motion Record on any Motion for reply shall be served and filed by 20-DEC-2013; accompanied by a letter as per paragraph 2. 9. Cross-examinations shall be completed by 1-APR-2014. 10. Novartis' Application Record shall be served and filed by 31-MAY-2014. 11. Cobalt's Application Record shall be served and filed by 31-JUL-2014. Filed on 07-FEB-2013 copies sent to parties entered in J. & O. Book, volume 1183 page(s) 130 - 132 Interlocutory Decision

Letter from Applicant dated 01-FEB-2013 further to their letter dated 25-JAN-2013: "...The parties are pleased to advise that they have reached an agreement with respect to confidentiality in this proceeding and that should the parties wish to rely upon confidential information during hearings before the Court we will seek to put a proper Protective Order in place prior to doing so." received on 01-FEB-2013

Communication to the Court from the Registry dated 28-JAN-2013 re: Letter dated 25-JAN-2013

Letter from Applicant dated 25-JAN-2013 further to their letter dated 18-JAN-2013; submitting a joint schedule for further steps to be taken in the proceeding. The parties also advise that they are negotiating the terms of a confidentiality order, and will provide an update by 1-FEB-2013. received on 25-JAN-2013

Letter from Applicant dated 18-JAN-2013 "...The Applicant would like to advise the Court that the parties are currently engaged in discussions pertaining to the next steps in this application, including document production and implementation of an agreed upon schedule. The Applicant respectfully proposes to report back to the Court on or before 25-JAN-2013 to advise of the next steps in this proceeding, as well as, whether a common schedule has been agreed upon by the parties." received on 18-JAN-2013

Notice of appearance on behalf of respondent,The Minister of Health with proof of service upon applicant and respondent Cobalt Pharmaceutical Company on 04-JAN-2013 filed on 09-JAN-2013

Solicitor's certificate of service on behalf of LIVIA AUMAND confirming service of doc. 8 upon Applicant by personal service on 07-JAN-2013 confirming service doc. 8 upon Respondent by telecopier on 07-JAN-2013 filed on 07-JAN-2013

Notice of appearance on behalf of Respondent Patentee, NOVARTIS AG, filed on 07-JAN-2013

Affidavit of service of Erin McIntomny sworn on 07-JAN-2013 on behalf of Applicant confirming service of doc. 1 upon Minister of Health and Novartis AG by personal service on 28-DEC-2012 filed on 07-JAN-2013

Affidavit of service of Natalie Sirota sworn on 03-JAN-2013 on behalf of Applicant confirming service of doc. 1 upon Cobalt Pharmaceuticals Company by process server on 02-JAN-2013 filed on 07-JAN-2013

Solicitor's certificate of service on behalf of Cheryl Cheung confirming service of doc. #4 upon all parties by telecopier on 04-JAN-2013 filed on 04-JAN-2013

Notice of appearance on behalf of the Respondent, Cobalt Pharmaceuticals Company filed on 04-JAN-2013

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 3 placed on file on 03-JAN-2013

Order dated 03-JAN-2013 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 03-JAN-2013 copies sent to parties entered in J. & O. Book, volume 1179 page(s) 324 - 324 Interlocutory Decision

Service copy of Doc. No. 1 with proof of service upon Minister of Health on 31-DEC-2012 filed on 31-DEC-2012

Notice of application and 2 copies with regard to S. 552(4) of the Patent Act and S.6 of the Patented Medicines (NOC) filed on 28-DEC-2012 Tariff fee of $50.00 received: yes